Pharmacotherapy for AuDHD: Evidence-Based Medication Management for Autism and ADHD Comorbidity

Pharmacotherapy for AuDHD: Evidence-Based Medication Management for Autism and ADHD ComorbidityA comprehensive clinical textbook addressing the unique challenges of medication management when autism spectrum disorder and attention-deficit/hyperactivity disorder co-occur. This evidence-based resource provides mental health professionals, physicians, and advanced practitioners with practical guidance for pharmacological treatment in this complex dual-diagnosis population.What This Textbook Covers:Professionals working with individuals who have both autism and ADHD face distinct clinical challenges requiring specialized knowledge. This textbook synthesizes current research, clinical trials, and best practices into an accessible, thoroughly referenced guide covering:Diagnostic considerations for identifying ADHD in autism populations, including modified assessment approaches and differential diagnosis complexitiesStimulant medications including methylphenidate and amphetamine formulations, with autism-specific dosing strategies, response rates, and side effect managementNon-stimulant options such as atomoxetine, guanfacine, and clonidine, with comparative effectiveness data and clinical selection criteriaAtypical antipsychotics for managing irritability and aggression when present alongside ADHD symptomsCombination pharmacotherapy strategies for treatment-resistant presentations and complex symptom profilesDevelopmental considerations across the lifespan from preschool through adulthoodComorbidity management addressing anxiety, depression, tic disorders, and sleep disturbancesBehavioral intervention integration for multimodal treatment approachesMedication discontinuation protocols and long-term outcome considerationsEvidence-Based Clinical Practice:Every chapter grounds recommendations in peer-reviewed research with over 500 verifiable citations from randomized controlled trials, systematic reviews, and landmark studies including Research Units on Pediatric Psychopharmacology (RUPP) findings. Detailed case studies throughout the text illustrate real-world application of concepts, demonstrating clinical decision-making processes.Who Should Read This Book:This textbook serves psychiatrists, developmental-behavioral pediatricians, psychiatric nurse practitioners, pediatricians, psychologists, clinical social workers, and other mental health professionals who prescribe or recommend medications for individuals with autism and ADHD. Graduate students in psychiatry, psychology, nursing, and social work will find comprehensive foundational knowledge, while experienced clinicians gain updated evidence and practical strategies.Unique Features:Neurodiversity-affirming approach respecting autism as natural variation while addressing impairing symptomsAutism-specific medication considerations including sensory sensitivities, communication differences, and restricted interests affecting treatmentComprehensive coverage of both pediatric and adult populationsIntegration of pharmacotherapy with behavioral, educational, and environmental interventionsDetailed discussion of informed consent, shared decision-making, and ethical considerationsCritical appraisal skills for evaluating new research and treatment claimsEmerging treatments and future research directions including pharmacogenomics and biomarkers Read more